← FDA Drug Approvals (Drugs@FDA)

BEIZRAY

NDA · New Drug Application · Sponsor: ZHUHAI · Approved 2024-10-23

Drug application

FDA Application #

NDA218711

Application type

New Drug Application

Brand name

BEIZRAY

Generic name

DOCETAXEL

Active ingredients

DOCETAXEL

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ZHUHAI

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2024-10-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown